Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)
CNY 13.6
(-1.16%)
CNY 13.6
(-1.16%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 842.41 Million CNY | -7.78% |
| 2022 | 913.52 Million CNY | 6.9% |
| 2021 | 854.54 Million CNY | 25.53% |
| 2020 | 680.75 Million CNY | 14.71% |
| 2019 | 593.45 Million CNY | 86.67% |
| 2018 | 317.92 Million CNY | 47.01% |
| 2017 | 216.25 Million CNY | 35.44% |
| 2016 | 159.66 Million CNY | 30.78% |
| 2015 | 122.08 Million CNY | 22.61% |
| 2014 | 99.57 Million CNY | 24.36% |
| 2013 | 80.07 Million CNY | 13.49% |
| 2012 | 70.55 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 78.68 Million CNY | -23.49% |
| 2024 Q1 | 161.97 Million CNY | -46.89% |
| 2024 Q2 | 102.84 Million CNY | -36.51% |
| 2023 Q1 | 161.61 Million CNY | -54.09% |
| 2023 FY | 842.41 Million CNY | -7.78% |
| 2023 Q2 | 215.18 Million CNY | 33.15% |
| 2023 Q4 | 304.97 Million CNY | 81.13% |
| 2023 Q3 | 168.37 Million CNY | -21.75% |
| 2022 Q1 | 200.82 Million CNY | -33.84% |
| 2022 Q4 | 352.03 Million CNY | 159.44% |
| 2022 Q3 | 135.69 Million CNY | -35.48% |
| 2022 Q2 | 210.31 Million CNY | 4.73% |
| 2022 FY | 913.52 Million CNY | 6.9% |
| 2021 FY | 854.54 Million CNY | 25.53% |
| 2021 Q3 | 181.75 Million CNY | -8.5% |
| 2021 Q4 | 303.52 Million CNY | 66.99% |
| 2021 Q1 | 168.3 Million CNY | -14.27% |
| 2021 Q2 | 198.64 Million CNY | 18.02% |
| 2020 Q3 | 196.31 Million CNY | 7.68% |
| 2020 FY | 680.75 Million CNY | 14.71% |
| 2020 Q4 | 196.31 Million CNY | 0.0% |
| 2020 Q2 | 182.31 Million CNY | 72.56% |
| 2020 Q1 | 105.65 Million CNY | -36.08% |
| 2019 Q3 | 165.28 Million CNY | 30.15% |
| 2019 Q2 | 126.99 Million CNY | 0.0% |
| 2019 Q4 | 165.28 Million CNY | 0.0% |
| 2019 Q1 | 126.99 Million CNY | 39.83% |
| 2019 FY | 593.45 Million CNY | 86.67% |
| 2018 Q2 | 67.13 Million CNY | -0.0% |
| 2018 FY | 317.92 Million CNY | 47.01% |
| 2018 Q4 | 90.81 Million CNY | 0.0% |
| 2018 Q3 | 90.81 Million CNY | 35.28% |
| 2018 Q1 | 67.13 Million CNY | 10.75% |
| 2017 Q3 | 60.61 Million CNY | 31.62% |
| 2017 Q2 | 46.05 Million CNY | 0.0% |
| 2017 FY | 216.25 Million CNY | 35.44% |
| 2017 Q4 | 60.61 Million CNY | 0.0% |
| 2017 Q1 | 46.05 Million CNY | 21.75% |
| 2016 Q2 | 41.69 Million CNY | -0.0% |
| 2016 FY | 159.66 Million CNY | 30.78% |
| 2016 Q3 | 37.83 Million CNY | -9.26% |
| 2016 Q1 | 41.69 Million CNY | 55.46% |
| 2016 Q4 | 37.83 Million CNY | 0.0% |
| 2015 Q4 | 26.81 Million CNY | 0.0% |
| 2015 Q2 | 34.22 Million CNY | 0.0% |
| 2015 Q3 | 26.81 Million CNY | -21.65% |
| 2015 Q1 | 34.22 Million CNY | 9.26% |
| 2015 FY | 122.08 Million CNY | 22.61% |
| 2014 Q4 | 31.32 Million CNY | 0.0% |
| 2014 Q2 | 23.89 Million CNY | 0.0% |
| 2014 Q1 | 23.89 Million CNY | -15.91% |
| 2014 FY | 99.57 Million CNY | 24.36% |
| 2013 Q4 | 28.42 Million CNY | 0.0% |
| 2013 FY | 80.07 Million CNY | 13.49% |
| 2012 FY | 70.55 Million CNY | 0.0% |